RECRUITINGOBSERVATIONAL
A Registry of AL Amyloidosis (ReAL)
A Registry to Investigate Real-world Natural History, Impact of Therapies and Patterns of Progression of AL Amyloidosis (ReAL)
About This Trial
The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.
Who May Be Eligible (Plain English)
Who May Qualify:
1. diagnosis of systemic AL amyloidosis;
2. treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
3. age ≥18 years;
4. ability to understand and willingness to sign an willing to sign a consent form (patients who already sign willing to sign a consent form for clinical data to be used in retrospective analyses will be accepted);
5. planned (or ongoing) follow-up at participating center.
Who Should NOT Join This Trial:
1. non-AL amyloidosis;
2. previous treatment for AL amyloidosis.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
1. diagnosis of systemic AL amyloidosis;
2. treatment-naïve (pre-treatment data collected at participating center available for retrospective part);
3. age ≥18 years;
4. ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted);
5. planned (or ongoing) follow-up at participating center.
Exclusion Criteria:
1. non-AL amyloidosis;
2. previous treatment for AL amyloidosis.
Locations (1)
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy